GridIron BioNutrients (MYYZ) Bioceutical Breakthrough May Hold the Key to the NFL’s Deadly CTE Crisis

You’ve seen it in the news – the NFL is facing a revenue-crushing epidemic.  CTE–the devastating brain disease stalking the NFL has sent dozens of companies scrambling for answers.  But while the NFL tries out $1,500 helmets and neurosurgeons on the sidelines, the surprising best answer may come from a plant. It turns out that cannabinoids could be an even more powerful neuroprotector than scientists had previously suspected [i]. And that means there are several companies in the MMJ and bioceuticals sphere that could be big winners.

Who will step up and become the next MMJ company to go ballistic? The obvious candidates include Axim Biotechnologies (OTC: AXIM), Golden Leaf (OTC: GLDFF), and GridIron BioNutrients (MYYZ).

 NFL Can’t Dodge The Need for Help

CTE or chronic traumatic encephalopathy is a specific type of permanent brain damage that is caused by multiple blows to the head over time. Doctors used to think it was rare. Then came the high-profile cases of athletes with the distinctive “tau” deposits of CTE getting in trouble or aging before their time. The average NFL pro sustains 1,500 blows to the head every season. The worst damage usually doesn’t show up until years later as depression, violent outbursts, aggression, speech disorders, trembling, seizures, difficulty walking, inability to focus, disordered thoughts, and memory loss so severe it looks like advanced Alzheimer’s.

CTE has become a publicity nightmare for the NFL. Former New England Patriot Aaron Hernandez, who committed suicide at age 27, had history of violence including murder… and the worst case of CTE ever seen in a player so young. Four-time Super Bowl champ and Hall of Famer Mike Webster suffered dementia at age 50. His brain showed tau deposits equivalent to being in 25,000 car crashes. The CTE-football link in today’s game is irrefutable. Researchers at Boston University have found evidence of CTE in 110 of the 111 brains of former NFL players it has autopsied.

Dr. Bennett Omalu, the neurologist who first pinpointed the problem in 2005, puts it starkly …“If you get to the professional level, I believe there is a 100% chance you have brain damage.”

Serious Problems Need Serious Answers

Golden Leaf (OTC:GLDFF) could be a company to watch as this controversial new sector picks up momentum. Golden Leaf prepares extracts for pens, cartridges and dabs and could easily become a cannabinoid supplier to another company. However, with its strong association to THC, the NFL will likely not want a direct link here.

Axim Biotechnologies (OTC: AXIM) has the same extraction advantages as Golden Leaf with a much more seriously medical brand. The company is doing well testing its Can-Chew gum to treat irritable bowel syndrome and glaucoma. It, too, could be a supplier in the chain that leads to an NFL product, but we don’t see it stepping up immediately.

The story is altogether different at GridIron BioNutrients (OTC: MYYZ). Not only does the company have a product aimed straight at the NFL… it already has a deal in the making. That’s a groundbreaking feat in its own right… and one that could make MYYZ a coveted acquisition target.

No other company is ready to market a sports-specific CBD drink. This is how investors find beverage stocks that soar, like VitaminWater, which Coca-Cola acquired for $4.1 billion. That’s approximately 17 times what Vitamin Water’s annual sales were at the time! Musician 50 CENT was a shareholder in Vitamin Water and it’s rumored he made $100 million for his share.

The Amazing Power of Cannabinoids to Cushion the Brain

Cannabinoids are already being prescribed for post-traumatic stress disorder, depression, anxiety, seizures, and pain. But research just released in 2017 added startling extra dimension. There is now solid proof that cannabinoids are good for the brain.  In the scientific jargon, it’s a neuroprotector—and a stronger one than anyone expected. New research establishes that cannabinoids protect the brains from the effects of ischemic strokes and head traumas.

With this proof in hand, MYYZ’s MVP Nano is game-ready, formulated, bottled and ready to save the game. But will the image-conscious National Football League approve of a drink with cannabinoids in it?

The National Football League Alumni Association already has!

 NFLA represents retired players and markets products through its Pro Football Legends division. It just signed a three-year memorandum of understanding to work with GridIron.

An innovative product line, access to capital, and a contract in place with the NFL Alumni Association… all signs point to a winning addition to your portfolio. The NFL has every reason to adopt a protective beverage like MVP Nano immediately. It lost a $1 billion lawsuit brought by former players with CTE. Young players are walking away early. And more and more parents won’t allow their children to learn how to play football in youth leagues and school sports anymore. Even LeBron James—who was a star wide receiver in high school and recruited by Notre Dame—won’t let his sons play football.

That’s why MVP Nano looks like the NFL’s best first shot at the CTE solution.

GridIron Is Run By Athletes for Athletes

GridIron’s CEO Dan Long is a former pro football player himself. That could be the reason that GridIron is the first and only Cannabinoid-enhanced product that we know of to reach a deal with the NFLA. But Long’s not just a jock. He understands what’s in the bottle and what the right nutrients and bioceuticals can achieve. He has a bachelor’s degree in nutrition from California State University, Long Beach. GridIron’s Treasurer and director Brian Martinho got his B.S. from San Diego State in Exercise and Nutritional Science. And Timothy Orr, GridIron’s president, has a JD from Gonzaga Law… but before that, he earned his B.A. in Biology from Whitworth University.

Acquisition Potential Is Sky High

If you know the beverage industry, you have probably figured out the real reason to own GridIron BioNutrients (OTC: MYYZ)—buyout potential. The giants of the industry rarely develop new products. They wait for young companies like GridIron to develop and test good ideas, then they pounce, often coughing up 4 to 17 X annual sales. Just the way PepsiCo bought Gatorade and Coke took over PowerAde.

GridIron BioNutrients is still in early development, itself having been only recently acquired by parent company MyCloudz.  That makes it an ideal time to stake out a speculative position for high rewards. Beverage stocks that find a new market can turn into real moonshot for investors—with share value rising as much as 20X like we saw with Samuel Adams or for an astounding 90X catapult, as we saw with Starbucks.

MYYZ is staking out an entirely new niche, and you don’t want to miss out on this one.  Take a look at the company’s website to find out more.

[i] and regarding brain trauma

Disclaimer: Please note we have been compensated $2500 for covering this story on MYYZ by Cream Consulting LLC for a period of 30 days.

By Steven Russell

Steve covers business and investing in emerging medical marijuana markets. Steve graduated from the university of New Orleans with a degree in Broadcast Journalism. Steve has published several articles in professional journals and magazines. His experience gives readers an inside look at the intersection of his specialties, business and medical marijuana.

Leave a Reply

Your email address will not be published. Required fields are marked *

Earth Science Tech, Inc. (OTCMKTS:ETST), GW Pharma (NASDAQ:GWPH), and Axim Biotechnologies, Inc. (OTCMKTS:AXIM) Provide Opportunities in the Cannabis Market for All Investors Can Medical Marijuana Inc (OTCMKTS:MJNA) breakout be on the horizon

Pin It on Pinterest